CINECA IRIS Institutional Research Information System

GASCO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.155
EU - Europa 7.514
AS - Asia 4.718
SA - Sud America 491
AF - Africa 112
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 17
Totale 24.047
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.946
CN - Cina 1.990
SG - Singapore 1.530
DE - Germania 1.278
IT - Italia 1.042
SE - Svezia 955
IE - Irlanda 860
UA - Ucraina 688
FR - Francia 561
FI - Finlandia 527
GB - Regno Unito 494
BR - Brasile 431
KR - Corea 362
AT - Austria 312
VN - Vietnam 274
PL - Polonia 264
CA - Canada 173
DK - Danimarca 147
IN - India 144
RU - Federazione Russa 98
JP - Giappone 76
BE - Belgio 65
ID - Indonesia 65
HK - Hong Kong 62
NL - Olanda 60
SN - Senegal 53
TW - Taiwan 53
GR - Grecia 43
ES - Italia 35
TR - Turchia 35
AU - Australia 30
UZ - Uzbekistan 26
MX - Messico 25
EG - Egitto 22
CH - Svizzera 17
EU - Europa 17
IQ - Iraq 16
IR - Iran 16
AR - Argentina 11
EC - Ecuador 11
JO - Giordania 11
ZA - Sudafrica 11
BD - Bangladesh 10
BG - Bulgaria 10
CL - Cile 10
PE - Perù 10
RO - Romania 10
NZ - Nuova Zelanda 9
CZ - Repubblica Ceca 8
LT - Lituania 8
HR - Croazia 7
NO - Norvegia 7
PK - Pakistan 7
SA - Arabia Saudita 7
VE - Venezuela 7
MU - Mauritius 6
TH - Thailandia 6
CO - Colombia 5
HU - Ungheria 5
IL - Israele 5
KE - Kenya 5
TN - Tunisia 5
AL - Albania 4
MA - Marocco 4
MY - Malesia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
CY - Cipro 3
DZ - Algeria 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
DO - Repubblica Dominicana 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PY - Paraguay 2
QA - Qatar 2
SC - Seychelles 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
CR - Costa Rica 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
PW - Palau 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 24.047
Salva come PNG Salva come JPEG
Città #
Chandler 1.347
Beijing 1.129
Ann Arbor 1.120
Dublin 855
Singapore 681
Fairfield 677
Santa Clara 586
Ashburn 552
Jacksonville 435
Houston 367
Dearborn 363
Woodbridge 363
Villeurbanne 305
Wilmington 302
Seattle 300
Vienna 296
Princeton 278
Torino 264
Warsaw 256
Medford 255
Nyköping 255
Frankfurt am Main 240
Dong Ket 223
Cambridge 216
Columbus 205
Pisa 190
Munich 180
Fremont 101
Milan 99
Redwood City 99
Boston 90
Boardman 76
Shanghai 76
Guangzhou 65
Jakarta 63
Brussels 62
Nanjing 61
Helsinki 54
Toronto 53
Hangzhou 52
Verona 51
Ottawa 50
Hong Kong 48
Turku 48
Hefei 47
Taipei 42
Falls Church 41
Norwalk 41
Turin 39
San Diego 37
Shenyang 36
Lachine 33
Zhengzhou 33
Nuremberg 32
New York 31
Düsseldorf 30
São Paulo 30
Washington 29
Jinan 25
Los Angeles 25
Pune 25
The Dalles 24
Phoenix 22
Kharkiv 21
Tokyo 21
Kunming 20
Monmouth Junction 20
Philadelphia 19
Wuhan 19
Silver Spring 18
Chengdu 17
Leinì 17
Nürnberg 17
Nanchang 16
Siena 16
Toledo 15
Cairo 14
Falkenstein 14
Amsterdam 13
Belo Horizonte 13
Hebei 13
Nottingham 13
Rome 13
Lansing 12
London 12
Mumbai 12
Tashkent 12
Bologna 11
Changsha 11
Copenhagen 11
Des Moines 11
Mountain View 11
Xian 11
Buffalo 10
Council Bluffs 10
Dallas 10
Rio de Janeiro 10
Fuzhou 9
Mexico City 9
Tianjin 9
Totale 14.520
Salva come PNG Salva come JPEG
Nome #
Quinone based nitric oxide donating compounds 612
1,2,5-Oxadiazole analogues of leflunomide and related compounds 465
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance 439
1,1-Dinitroethyl substituted furoxans : a new class of vasodilators and inhibitors of platelet aggregation 369
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 333
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance 325
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells 323
Doxorubicin-antioxidant multitarget drugs 303
New furoxan derivatives for the treatment of ocular hypertension 303
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease 284
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors. 282
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 281
New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold 262
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity 253
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile 234
Edaravone derivatives containing NO-donor functions 233
4-Hydroxy-1,2,5-oxadiazol-3-yl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Molecular Pharmacological Characterization at Ionotropic Glutamate Receptors of Compounds Related to Glutamate and Its Homologues 230
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery 230
Composti ibridi per il trattamento della malaria cerebrale 219
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 217
1,4-Dihydropyridines containing R-NNO-azoxy moieties 215
Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein 200
Combination of PDT and NOPDT with a tailored BODIPY derivative 197
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs 191
New nitric oxide or hydrogen sulfide releasing aspirins 187
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria 186
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light 183
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 179
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 179
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth 169
Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells 167
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. 166
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation. 165
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells 162
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 158
A new class of NO-donor H3-Antagonists 156
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization 154
Synthesis and biological evaluation of the first example of NO-donor histone deacetylase inhibitor 153
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae 150
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity 150
Multitarget Drugs: Synthesis and Preliminary Pharmacological Characterization of Zileuton Analogues Endowed with Dual 5-LO Inhibitor and NO-Dependent Activities 148
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties 145
Amphiphilic NO-Donor Antioxidants 144
Activation of endothelial guanylate cyclase inhibits cellular reactivity. 143
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 143
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents 143
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid 140
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans 140
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs 139
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization 138
Use of Nitric Oxide Releasing Furoxan System in the Design of "Hybrids": Substitution of Furoxan Moieties for the Furan Ring in Prazosin 137
Multitarget Drugs: Focus on the NO-donor hybrid drugs 133
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light 133
Carnosine analogues containing Phenol substructures 132
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties 131
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor 130
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni 128
NO-donors: focus on furoxan derivatives 128
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma 125
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile 124
Synthesis, physico-chemical characterization, andbiological activities of new carnosine derivatives stablein human serum as potential neuroprotective agents 124
A new class of ibuprofen derivatives with reduced gastrotoxicity 119
A novel hybrid aspirin-NO releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages 118
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 117
SAR STUDIES ON H2 ANTAGONISTS CONTAINING ALKYLAMINO SUBSTITUTED 1,2,5-THIADIAZOLE 1-OXIDE MOIETIES 116
Synthesis and pharmacological characterisation of new H2-antagonists containing NO-donor moieties, endowed with mixed antisecretory and gastroprotective activities. 116
Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-1 115
DNA-targeted NO release photoregulated by green light 115
Inhibition of Human Placenta Glutathione Transferase P1-1 by the Antibiotic Calvatic Acid and its Diazocyanide Analogue: Evidence for Multiple Catalytic Intermediates 114
ALPHA(1)-ADRENOCEPTOR BLOCKING ACTIVITY OF SOME RING-OPEN ANALOGS OF PRAZOSIN 114
Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets. 113
Anti-Helicobacter pylori Agents Endowed with H2-antagonist Properties 113
New potential uroselective NO-donor a1-antagonists 112
[3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties 112
Activité contre les Microorganismes de dex Pyrazolyldiazène carbonitriles Oxyde-2 112
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 111
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity 111
Synthesis and Structure of a Trimer of the Furoxan System with High Vasodilator and Platelet Antiaggregatory Activity 111
A new furoxan NO-donor rabeprazole derivative and related compounds 110
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 110
6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: A new scaffold endowed with potent CDK2 inhibitory activity 107
Characterisation of Furoxancarbonitriles as a New Class of Vasodilators 107
Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives 106
Activity of calvatic acid and its analogs against Helicobacter pylori 106
A Directed Synthesis of Alkyl, Aryl, and Heteroaryl-ONN-azoxycyanides 106
A NEW CLASS OF FUROXAN DERIVATIVES AS NO DONORS - MECHANISM OF ACTION AND BIOLOGICAL-ACTIVITY 105
NO-donor Carnosine Derivatives As Potential Neuroprotective Agents 104
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells. 103
Oximation of Acetyl(hydroxyimino)acetone: Nuclear Magnetic Resonance Spectroscopic, Chemical, and X-Ray Crystallographic Studies of the Reaction Products 103
Furoxan derivatives as NO-donors 101
Pharmacochemistry of the Furoxan Ring : Recent Developments 100
Use of the furoxan (1,2,5-oxadiazole 2-oxide) system in the design of new NO-donor antioxidant hybrids 99
Glutathione potentiates cGMP synthesis induced by the two phenylfuroxancarbonitrile isomers in RFL-6 cells. 99
CC1000: a new cardioprotective agent against ischemia/reperfusion injuries 99
Unsymmetrically Substituted Furoxans. VII. A 13C NMR Study of a Series of Isomeric Pairs of Furoxans and the Structure of the two Isomeric Chlorophenyl furoxans 99
Unsymmetrically substituted furoxans. Part 16 [1]. Reaction of benzenesulfonyl substituted furoxans with ethanol and ethanethiol in basic medium 98
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 98
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties 97
13C and 15N Solution and Solid-state Nuclear Magnetic Resonance Study of the Intermolecular interactions in the 1:1 Trimethoprim:Sulphamethoxazole Complex 97
Novel Organic Nitrate Esters 96
Totale 16.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.524
article - articoli 0
book - libri 0
conference - conferenze 10.319
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.843
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.297 211 159 167 107 175 141 154 119 345 193 139 387
2021/20223.161 153 131 175 248 231 68 292 212 103 307 648 593
2022/20233.662 446 364 105 380 280 882 400 207 321 83 119 75
2023/20241.398 171 223 102 75 115 194 51 56 17 84 101 209
2024/20254.137 56 275 169 380 877 250 115 185 637 220 335 638
2025/2026123 123 0 0 0 0 0 0 0 0 0 0 0
Totale 24.762